Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $8.7 million.

  • Kiniksa Pharmaceuticals International's Tax Provisions rose 5881.28% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 26593.08%. This contributed to the annual value of $7.0 million for FY2024, which is 12290.8% up from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Tax Provisions is $8.7 million, which was up 5881.28% from $5.0 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's Tax Provisions' 5-year high stood at $8.7 million during Q3 2025, with a 5-year trough of -$177.4 million in Q3 2022.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's median Tax Provisions value was $1.9 million (recorded in 2022), while the average stood at -$9.2 million.
  • Data for Kiniksa Pharmaceuticals International's Tax Provisions shows a peak YoY increase of 81666.67% (in 2022) and a maximum YoY decrease of 15020338.98% (in 2022) over the last 5 years.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Tax Provisions (Quarter) stood at $279000.0 in 2021, then surged by 753.05% to $2.4 million in 2022, then plummeted by 1057.44% to -$22.8 million in 2023, then surged by 64.49% to -$8.1 million in 2024, then skyrocketed by 207.8% to $8.7 million in 2025.
  • Its Tax Provisions stands at $8.7 million for Q3 2025, versus $5.0 million for Q2 2025 and $7.0 million for Q1 2025.